Original filing (PDF)20250407151336NAL0027099888001

MARRAS PHARMA CORP

Name: MARRAS PHARMA CORP — MARRAS PHARMA CORP 401(K) PROFIT SHARING PLAN & TRUST, Form 5500 (2024)
Creator: MARRAS PHARMA CORP

Form 5500-SF

FILING_RECEIVED

MARRAS PHARMA CORP 401(K) PROFIT SHARING PLAN & TRUST

401(k) retirement plan

Active participants

Accounts w/ balance

Plan assets (EOY)

$2.1M

Net assets (EOY)

$2.1M

Plan health score (directional)

/ 100

Grade A

Top-tier plan health

Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.

Compliance & disclosures

100

Concentration risk

Total plan cost

Vendor stack

100

Participation health

Decision-maker contacts

CFO / Head of HR / Benefits Manager — verified email + LinkedIn for MARRAS PHARMA CORP.

Plan sponsor

Name

MARRAS PHARMA CORP

EIN

85-4369315

Address

217 REMSEN ST · COHOES, NY · 120473024

Phone

(917) 568-9000

Industry

Wholesale Tradesee all

Plan administrator

Name

ERISA FIDUCIARY SERVICES, INC.

EIN

47-1637791

City

HAUPPAUGE, NY

Phone

(631) 249-0500

Plan characteristics

Plan number

001

Plan year

2024

Plan year begin

2024-01-01

Tax period

2024-12-31

Filed

2025-04-07

Pension benefit codes

2E · Profit-sharing

2F · ERISA section 404(c)

2G · Total participant-directed accounts

2J · 401(k) feature

2K · 401(m) arrangement

2T · Default investment account (QDIA)

3D · Pre-approved plan (master / prototype / VS)

Audit & trust (Schedule H)

Service providers (Schedule C)

Small plans don't disclose service providers

Related plans

Similar-size Wholesale Trade plans

GENEXA INC.

GENEXA 401(K) PROFIT SHARING PLAN

$2.1M · 26 participants

THE TETRA CORPORATION

TETRA PROFIT SHARING PLAN

$2.1M · 16 participants

GEDEON RICHTER USA, INC.

GEDEON RICHTER USA, INC. 401(K) PROFIT SHARING PLAN

$2.1M · 2 participants

DEDMON PHARMACY, INC.

DEDMON PHARMACY, INC. 401(K) PROFIT SHARING PLAN

$2.1M · 14 participants

CENTRIENT PHARMACEUTICALS USA, INC.

CENTRIENT PHARMACEUTICALS USA, INC. 401(K) PLAN

$2.1M · 3 participants